about
Allopurinol Resistance in Leishmania infantum from Dogs with Disease RelapsePlasmodium-induced inflammation by uric acidEfficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis.Biological action of inosine analogs in Leishmania and Trypanosoma spp.TOR-induced resistance to toxic adenosine analogs in Leishmania brought about by the internalization and degradation of the adenosine permease.Trypanocidal activity of antitumor antibiotics and other metabolic inhibitors.Antileishmanial drug targeting through glycosylated polymers specifically internalized by macrophage membrane lectins.Pyrimidine metabolism in Tritrichomonas foetus.Nobel Lecture. The purine path to chemotherapy.Pyrazolopyrimidine metabolism in Leishmania and trypanosomes: significant differences between host and parasite.Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis.Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptakeComparative effects of 4-aminopyrazolopyrimidine, its 2'-deoxyriboside derivative, and allopurinol on in vitro growth of American Leishmania species.Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.Resistance of Leishmania infantum to allopurinol is associated with chromosome and gene copy number variations including decrease in the S-adenosylmethionine synthetase (METK) gene copy number
P2860
Q28552396-05A5846E-15E2-4C48-A293-03FE01400F9CQ33325912-41AB22E1-DDF8-4ABD-B945-C4B4B6308246Q35639856-6C13B1EA-F4B4-43DC-8821-F1C36E4F2539Q35757176-DDD2820F-ADF2-4ACF-929E-A9FBD534AD21Q35972458-CCA2B6D1-3339-457F-9FC2-A13C51FD6370Q36469458-86C8A6F4-96DE-46D7-AF78-13DC5C74360AQ36757841-0922BF55-5268-4CA8-A2A5-3B2B3A6FBE09Q37610280-B7AE242E-54C9-42A2-AA25-9DC1E4038452Q38707737-73B88EFE-74E6-4336-B594-BB51796D969BQ39216994-C732E58A-CD7D-45B4-AA40-2BB9D979BE5EQ39506821-D3EEA22A-6C4B-4DA3-8186-7CE4A5B12A2FQ40368500-ABF60D9D-05E1-4760-BFC9-FCD52C0DAC03Q42042666-FB8D7D89-2D10-4BFB-8860-859266445CB7Q42173107-8BEED082-9268-4BC4-887B-A0831E8A62CFQ48406876-51142330-7DCD-48CB-8801-C6148359C407Q54461258-3395CA57-0C4D-4CA3-9F10-1AB03F4C86EAQ58711926-1443EA8B-FEF0-4589-B245-895AB9F96D19
P2860
description
1974 nî lūn-bûn
@nan
1974 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1974 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
name
Antileishmanial effect of allopurinol.
@ast
Antileishmanial effect of allopurinol.
@en
Antileishmanial effect of allopurinol.
@nl
type
label
Antileishmanial effect of allopurinol.
@ast
Antileishmanial effect of allopurinol.
@en
Antileishmanial effect of allopurinol.
@nl
prefLabel
Antileishmanial effect of allopurinol.
@ast
Antileishmanial effect of allopurinol.
@en
Antileishmanial effect of allopurinol.
@nl
P2860
P356
P1476
Antileishmanial effect of allopurinol.
@en
P2093
P2860
P304
P356
10.1128/AAC.5.5.469
P407
P577
1974-05-01T00:00:00Z